Clayman Michael D.

USNatural personCEO

Insider

Clayman Michael D.

USNatural personCEO

Transactions

Issuers

Buys / Sells

16/1

Last tx

19 Nov 2021

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Akebia Therapeutics, Inc.	12,500	reported	14 Jun 2018	tx 6+57,500
Flexion Therapeutics Inc	0	reported	19 Nov 2021	tx 91+2,590,440−5,694,291

Recent transactions

Date	Type	Issuer	Qty	Price
19 Nov 2021	OTHER	Flexion Therapeutics Inc	335,498	8.50 USD
19 Nov 2021	OTHER	Flexion Therapeutics Inc	373,769	8.50 USD
19 Nov 2021	OTHER	Flexion Therapeutics Inc	24,600	8.50 USD
19 Nov 2021	OTHER	Flexion Therapeutics Inc	388,683	8.50 USD
19 Nov 2021	OTHER	Flexion Therapeutics Inc	175,000	—

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Akebia Therapeutics, Inc.	12,500	reported	14 Jun 2018	tx 6+57,500
Flexion Therapeutics Inc	0	reported	19 Nov 2021	tx 91+2,590,440−5,694,291

Recent transactions

Date	Type	Issuer	Qty	Price
19 Nov 2021	OTHER	Flexion Therapeutics Inc	335,498	8.50 USD
19 Nov 2021	OTHER	Flexion Therapeutics Inc	373,769	8.50 USD
19 Nov 2021	OTHER	Flexion Therapeutics Inc	24,600	8.50 USD
19 Nov 2021	OTHER	Flexion Therapeutics Inc	388,683	8.50 USD
19 Nov 2021	OTHER	Flexion Therapeutics Inc	175,000	—